Type 2 diabetes. Routine ACE inhibitors?
Hönl, S.B.
Medizinische Monatsschrift für Pharmazeuten 31(4): 149-150
2008
ISSN/ISBN: 0342-9601 PMID: 18497249 Document Number: 621065
Document emailed within 1 workday
Related Documents
Kawamori, R. 2011: The expectation for DPP-4 inhibitors on future treatment of type 2 diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 69(8): 1515-1519Chronister, C.L.; Gurwood, A.S. 1998: Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients Journal of the American Optometric Association 69(11): 695-698
Scheen, A.J. 2015: How i TREAT ... THE ROLE OF DPP-4 INHIBITORS (GLIPTINS) IN THE TREATMENT OF TYPE 2 DIABETES Revue Medicale de Liege 70(12): 593-599
Philips, J-Christophe.; Paquot, N.; Scheen, A.J. 2019: Potential role of SGLT2 inhibitors in the management of type 1 diabetes Revue Medicale Suisse 15(659): 1426-1430
Shetty, A.S.; Nandith, A.; Snehalath, C.; Ramachandran, A. 2013: Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes Journal of the Association of Physicians of India 61(8): 543-544
Panikar, V.; Joshi, S.R.; Deogaonkar, N.; Vadgama, J.; Nasikkar, N.; Kamat, T.; Sheikh, S.; Jain, C.C.; Wagle, T. 2018: Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic Drugs Journal of the Association of Physicians of India 66(12): 46-49
Wadström, J.; Gannedahl, G.; Wahlberg, J.; Frödin, L.; Tedbrandt, A.; Berne, C. 1994: Development of type Ii diabetes after combined kidney-pancreas transplantation in a patient with type i (insulin-dependent) diabetes Transplantation Proceedings 26(3): 1761-1762
De Sanctis, V. 2018: Type 1 and Type 2 diabetes in children and adolescents: a public health problem in Qatar. The experience of Pediatric Diabetes Center at Hamad General Hospital (HGH) of Doha Acta Bio-Medica: Atenei Parmensis 89(S5): 5-6
Tuomilehto, J.; Lindström, J. 2003: The principal trials for prevention of type 2 diabetes have now confirmed that type 2 diabetes can be prevented by life style changes. Prevention of type 2 diabetes by life style Journees Annuelles de Diabetologie de l'Hotel-Dieu 2003: 77-89
Bonnici, F.; Omar, M.A. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors have a more beneficial effect on biochemical parameters than low-dose thiazides South African Medical Journal 80(5): Suppl 6
Likitmaskul, S.; Wacharasindhu, S.; Rawdaree, P.; Ngarmukos, C.; Deerochanawong, C.; Suwanwalaikorn, S.; Chetthakul, T.; Bunnag, P.; Kosachunhanun, N.; Plengvidhaya, N.; Leelawatana, R.; Krittiyawong, S.; Benjasuratwong, Y.; Pratipanawatr, T. 2006: Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes Journal of the Medical Association of Thailand 89(Suppl 1): S10-S16
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Lindström, J.; Neumann, A.; Sheppard, K.E.; Gilis-Januszewska, A.; Greaves, C.J.; Handke, U.; Pajunen, P.; Puhl, S.; Pölönen, A.; Rissanen, A.; Roden, M.; Stemper, T.; Telle-Hjellset, V.; Tuomilehto, J.; Velickiene, D.; Schwarz, P.E.; Acosta, T.; Adler, M.; AlKerwi, A.; Barengo, N.; Barengo, R.; Boavida, J.M.; Charlesworth, K.; Christov, V.; Claussen, B.; Cos, X.; Cosson, E.; Deceukelier, S.; Dimitrijevic-Sreckovic, V.; Djordjevic, P.; Evans, P.; Felton, A-M.; Fischer, M.; Gabriel-Sanchez, R.; Gilis-Januszewska, A.; Goldfracht, M.; Gomez, J.L.; Greaves, C.J.; Hall, M.; Handke, U.; Hauner, H.; Herbst, J.; Hermanns, N.; Herrebrugh, L.; Huber, C.; Hühmer, U.; Huttunen, J.; Jotic, A.; Kamenov, Z.; Karadeniz, S.; Katsilambros, N.; Khalangot, 2010: Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe Hormone and Metabolic Research 42 Suppl. 1: S37-S55
Jialal, I.; Rajput, M.C.; Desai, R.K. 1987: The occurrence of Z-type diabetes (tropical pancreatic diabetes) in the South African Indian South African Medical Journal 71(4): 221-223
Majeed, A.; Newnham, A.; Ryan, R.; Khunti, K. 2002: Prevention and cure of type 2 diabetes. General practitioners are treating more cases of diabetes Bmj 325(7370): 965
Kida, Y. 2006: Autonomic neuropathy in type-2 diabetes, lessons from Okamoto Diabetes Study Rinsho Shinkeigaku 46(11): 871-873
Liebl, A.; Goertz, A.; Henkel, B.; Spannheimer, A. 2000: Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year? MMW Fortschritte der Medizin 142(23): 39-42
Kozarova, M.; Javorsky, M.; Stancakova, A.; Dobrikova, M.; Habalova, V.; Klimcakova, L.; Zidzik, J.; Haluskova, J.; Salagovic, J.; Tkac, I. 2010: Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population Bratislavske Lekarske Listy 111(3): 150-152
Chetthakul, T.; Deerochanawong, C.; Suwanwalaikorn, S.; Kosachunhanun, N.; Ngarmukos, C.; Rawdaree, P.; Krittiyawong, S.; Leelawatana, R.; Bunnag, P.; Plengvidhya, N.; Pratipanawatr, T.; Benjasuratwong, Y.; Mongkolsomlit, S. 2006: Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus Journal of the Medical Association of Thailand 89(Suppl 1): S27-S36